Serotonin Pathophysiology: Mechanistic Role and Therapeutic Strategies

Thursday, December 12, 2019, 8:00 AM - Saturday, December 12, 2020, 11:59 PM

AMA PRA Category 1 Credits™ (0.50 hours), AMA PRA Category 1 Credits™ Designated (0.50 hours)

This is an enduring activity based upon a live presentation of the role of serotonin and its impact on carcinoid syndrome delivered at the 2019 NANETS annual conference in Boston, Massachusetts.

This video-based program features peer-to-peer expert exchange and authoritative insights, opinions, and perspectives related to neuroendocrine tumors (NETS) and carcinoid syndrome.

Serotonin plays a central role in the physiology of carcinoid syndrome by promoting intestinal motility and therefore the pathophysiology of serotonin is important for physicians to understand in order to provide symptom management and better patient care.

This program will give learners a novel approach to better understanding the mechanistic basis of cellular function, the role that serotonin plays on hormonal dysregulation, symptoms and management and an enhanced understanding of the mechanism of action of serotonin in the body.

There are no fees for participating in and receiving CME credit for this enduring material activity.

1. Discuss why serotonin is important to understand in order to best manage patients with carcinoid syndrome;
2. Discuss with an increased comfort level the pathophysiology and mechanistic activity of serotonin and its role in disease so that they may provide the right therapy for the right patient at the right time.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and Intellisphere, LLC. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

The University of Cincinnati designates this enduring material activity for a maximum of .50 AMA PRA Category 1 Credits™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.

FACULTY AND DISCLOSURE / CONFLICT OF INTEREST POLICY

In accordance with ACCME requirements, the University of Cincinnati College of Medicine has a conflict of interest policy that requires, all faculty, planning committee members, and other individuals who are in a position to control content, to disclose any relevant relationships with any commercial interest related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence. Disclosure will be made at the time of activity.

Daniel M. Halperin, MD has noted the following relationships Contracted Research-Genentech, Takeda, and Thermo Fischer|Consultant-Lexicon Pharmaceuticals, Ipsen, and Advances Accelerator Applications

University of Cincinnati staff members, Intellisphere LLC, and the peer/content reviewers for this activity have no relevant financial relationships to disclose.

Medical Director & Program Planners

Intellisphere, LLC
Marisa Fennekohl, HMCC 
Leonard Lionnet, PhD, ISMPP, CMPP
Ronald W. Niebo

University of Cincinnati Continuing Medical Education Office
Bruce Gebhardt, MD, Professor, Physician Reviewer
Susan P. Tyler, MEd, CMP, CHCP, Director
Heather Muskopf, Program Manager

Disclaimer Statement
The opinions expressed during the live activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees; professional development.

Off-Label Disclosure Statement
Faculty members are required to inform the audience when they are discussing off-label, unapproved uses of devices and drugs. Physicians should consult full prescribing information before using any product mentioned during this educational activity.

This educational activity is supported by an educational grant from Lexicon Pharmaceuticals.